Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James B Geake

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Case Reports in Immunology|November 7, 2014
Acute spontaneously resolving pulmonary vasculitis: a case reportJames B Geake, Graeme Maguire
Therapeutics and Clinical Risk Management|October 6, 2016
Long-term safety of tiotropium delivered by Respimat<sup>®</sup> SoftMist™ Inhaler: patient selection and special considerationsChing Kuo Tan, Gui Quan Say, James B Geake
The Cochrane Database of Systematic Reviews|January 10, 2015
Indacaterol, a once-daily beta2-agonist, versus twice-daily beta₂-agonists or placebo for chronic obstructive pulmonary diseaseJames B Geake, Eli J Dabscheck, Richard Wood-Baker, et al.
Vaccines|April 23, 2025
Efficacy of Bacille Calmette-Guérin Against COVID-19 Hospitalisation: A Meta-Analysis and Systematic Review of Randomised Control TrialsJoseph Inauen, Sam LaBroome, Antonietta Maldari, et al.
Mbio|April 13, 2017
Within-Host Evolution of <i>Burkholderia pseudomallei</i> during Chronic Infection of Seven Australasian Cystic Fibrosis PatientsLinda T Viberg, Derek S Sarovich, Timothy J Kidd, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 13, 2016
The changing prevalence of pulmonary infection in adults with cystic fibrosis: A longitudinal analysisKay A Ramsay, Harpreet Sandhu, James B Geake, et al.
BMC Pulmonary Medicine|October 11, 2015
An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosisJames B Geake, David W Reid, Bart J Currie, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Case Reports in Immunology|November 7, 2014
Acute spontaneously resolving pulmonary vasculitis: a case reportJames B Geake, Graeme Maguire
Therapeutics and Clinical Risk Management|October 6, 2016
Long-term safety of tiotropium delivered by Respimat<sup>®</sup> SoftMist™ Inhaler: patient selection and special considerationsChing Kuo Tan, Gui Quan Say, James B Geake
The Cochrane Database of Systematic Reviews|January 10, 2015
Indacaterol, a once-daily beta2-agonist, versus twice-daily beta₂-agonists or placebo for chronic obstructive pulmonary diseaseJames B Geake, Eli J Dabscheck, Richard Wood-Baker, et al.
Vaccines|April 23, 2025
Efficacy of Bacille Calmette-Guérin Against COVID-19 Hospitalisation: A Meta-Analysis and Systematic Review of Randomised Control TrialsJoseph Inauen, Sam LaBroome, Antonietta Maldari, et al.
Mbio|April 13, 2017
Within-Host Evolution of <i>Burkholderia pseudomallei</i> during Chronic Infection of Seven Australasian Cystic Fibrosis PatientsLinda T Viberg, Derek S Sarovich, Timothy J Kidd, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 13, 2016
The changing prevalence of pulmonary infection in adults with cystic fibrosis: A longitudinal analysisKay A Ramsay, Harpreet Sandhu, James B Geake, et al.
BMC Pulmonary Medicine|October 11, 2015
An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosisJames B Geake, David W Reid, Bart J Currie, et al.
Pageof 1